CorVel Announces Revenues and Earnings
CorVel Corporation (NASDAQ: CRVL) reported its financial results for the quarter and fiscal year ending March 31, 2021. Earnings per share for Q4 rose to $0.81, up from $0.64 year-over-year, despite a revenue decrease to $146 million from $147 million. For the fiscal year, EPS remained stable at $2.55, but revenues dropped to $553 million, down from $592 million in the previous year. The company noted significant growth in its CERiS health market segment and continues to leverage technology and AI for improved operations. CorVel also celebrated its 30th anniversary on NASDAQ.
- Earnings per share for Q4 increased to $0.81, a 26.6% rise YOY.
- Despite revenue declines, EPS remained stable at $2.55 for the fiscal year.
- Significant growth reported in CERiS health market segment.
- Investment in AI and machine learning to drive innovation and efficiency.
- Q4 revenues declined to $146 million from $147 million YOY.
- Fiscal year revenue fell to $553 million, down from $592 million in the previous year.
IRVINE, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2021. Earnings per share for the quarter were
Earnings per share for the fiscal years ended March 31, 2021 and March 31, 2020 were
CERiS, which focuses primarily on the health market, had significant growth during the quarter. Their comprehensive prospective claim review service expanded with new and existing client partners for both itemized bills and DRG validation. The dual reviews validate coding and identify invalid charges within prompt payment requirements, resulting in industry-leading results to health plans and TPAs.
Technology has and will continue to be a key differentiator for CorVel. The company remains committed to utilizing emerging technology to improve business processes and reduce repetitive human interaction. Artificial intelligence is a primary driver of innovation, and we are expanding our investment in machine learning to guide actions and decisions towards optimal outcomes.
This year, CorVel celebrates its 30th anniversary on NASDAQ. Since its foundation, the company has endeavored to make a substantial difference in the lives of team members, business partners, and the industry at large. In addition, CorVel strives to be a workplace that encourages learning, growth, and advancement, and was pleased to have been awarded certification as a Great Place to Work®.
About CorVel
CorVel Corp. applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. We partner with employers, third-party administrators, insurance companies and government agencies in managing workers’ compensation and health, auto and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, statements relating to the Company’s health market prospective claim review services and the Company’s continued investment in machine learning, artificial intelligence and other innovative technologies, and statements relating to the Company’s strategic alliances within the healthcare market. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement, including the risk that the impact of the COVID-19 pandemic on our business, results of operations and financial condition is greater than our initial assessment.
The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2020 and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2020, September 30, 2020, and December 31, 2020. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.
CorVel Corporation
Quarterly and Fiscal Results – Income Statement
Quarters and Fiscal Year Ended March 31, 2021 and March 31, 2020
| Quarter Ended | March 31, 2021 | March 31, 2020 | ||||||
| Revenues | $ | 145,510,000 | $ | 147,024,000 | ||||
| Cost of revenues | 109,791,000 | 116,333,000 | ||||||
| Gross profit | 35,719,000 | 30,691,000 | ||||||
| General and administrative | 16,366,000 | 15,865,000 | ||||||
| Income from operations | 19,353,000 | 14,826,000 | ||||||
| Income tax provision | 4,544,000 | 3,079,000 | ||||||
| Net income | $ | 14,809,000 | $ | 11,747,000 | ||||
| Earnings Per Share: | ||||||||
| Basic | $ | 0.83 | $ | 0.65 | ||||
| Diluted | $ | 0.81 | $ | 0.64 | ||||
| Weighted Shares | ||||||||
| Basic | 17,902,000 | 18,074,000 | ||||||
| Diluted | 18,196,000 | 18,325,000 | ||||||
| Fiscal Year Ended | March 31, 2021 | March 31, 2020 | ||||||
| Revenues | $ | 552,644,000 | $ | 592,225,000 | ||||
| Cost of revenues | 429,020,000 | 466,304,000 | ||||||
| Gross profit | 123,624,000 | 125,921,000 | ||||||
| General and administrative | 64,449,000 | 65,210,000 | ||||||
| Income from operations | 59,175,000 | 60,711,000 | ||||||
| Income tax provision | 12,819,000 | 13,334,000 | ||||||
| Net income | $ | 46,356,000 | $ | 47,377,000 | ||||
| Earnings Per Share: | ||||||||
| Basic | $ | 2.59 | $ | 2.59 | ||||
| Diluted | $ | 2.55 | $ | 2.55 | ||||
| Weighted Shares | ||||||||
| Basic | 17,930,000 | 18,326,000 | ||||||
| Diluted | 18,166,000 | 18,602,000 | ||||||
CorVel Corporation
Quarterly Results – Condensed Balance Sheet
March 31, 2021 and March 31, 2020
| March 31, 2021 | March 31, 2020 | |||||||
| Cash | $ | 139,716,000 | $ | 83,223,000 | ||||
| Customer deposits | 56,497,000 | 48,991,000 | ||||||
| Accounts receivable, net | 64,722,000 | 65,767,000 | ||||||
| Prepaid taxes and expenses | 8,006,000 | 11,010,000 | ||||||
| Property, net | 70,619,000 | 75,900,000 | ||||||
| Goodwill and other assets | 39,876,000 | 40,703,000 | ||||||
| Right-of-use asset, net | 45,324,000 | 90,666,000 | ||||||
| Total | $ | 424,760,000 | $ | 416,260,000 | ||||
| Accounts and taxes payable | $ | 13,574,000 | $ | 16,363,000 | ||||
| Accrued liabilities | 148,886,000 | 117,326,000 | ||||||
| Deferred tax liability | — | 7,764,000 | ||||||
| Long-term lease liabilities | 41,898,000 | 85,096,000 | ||||||
| Paid-in capital | 185,944,000 | 168,938,000 | ||||||
| Treasury stock | (564,435,000 | ) | (531,764,000 | ) | ||||
| Retained earnings | 598,893,000 | 552,537,000 | ||||||
| Total | $ | 424,760,000 | $ | 416,260,000 | ||||
| CorVel Corporation |
| 1920 Main Street |
| Suite 900 |
| Irvine, CA 92614 |
| Contact: Melissa Storan |
| Phone: 949-851-1473 |
| www.corvel.com |
FAQ
What were CorVel's earnings per share for the quarter ending March 31, 2021?
How much did CorVel's revenues decrease in the fiscal year ended March 31, 2021?
What growth did CorVel experience in its CERiS health market segment?
What technology initiatives is CorVel focusing on?
